ACTA1 and metabolic dysfunction-associated steatohepatitis: More importantly, we found that Runx2 and α‐SMA were both markedly increased in non‐alcoholic steatohepatitis (NASH)‐related liver fibrosis induced by high‐fat diet treatment (Figure 1H).